rs115057256

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_052813.5(CARD9):​c.870G>A​(p.Ala290Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00215 in 1,609,816 control chromosomes in the GnomAD database, including 66 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.011 ( 37 hom., cov: 34)
Exomes 𝑓: 0.0012 ( 29 hom. )

Consequence

CARD9
NM_052813.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -8.75

Publications

3 publications found
Variant links:
Genes affected
CARD9 (HGNC:16391): (caspase recruitment domain family member 9) The protein encoded by this gene is a member of the CARD protein family, which is defined by the presence of a characteristic caspase-associated recruitment domain (CARD). CARD is a protein interaction domain known to participate in activation or suppression of CARD containing members of the caspase family, and thus plays an important regulatory role in cell apoptosis. This protein was identified by its selective association with the CARD domain of BCL10, a postive regulator of apoptosis and NF-kappaB activation, and is thought to function as a molecular scaffold for the assembly of a BCL10 signaling complex that activates NF-kappaB. Several alternatively spliced transcript variants have been observed, but their full-length nature is not clearly defined. [provided by RefSeq, Jul 2008]
CARD9 Gene-Disease associations (from GenCC):
  • deep dermatophytosis
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • predisposition to invasive fungal disease due to CARD9 deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 9-136370375-C-T is Benign according to our data. Variant chr9-136370375-C-T is described in ClinVar as Benign. ClinVar VariationId is 365843.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-8.75 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0114 (1744/152352) while in subpopulation AFR AF = 0.0396 (1645/41584). AF 95% confidence interval is 0.038. There are 37 homozygotes in GnomAd4. There are 845 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 37 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CARD9NM_052813.5 linkc.870G>A p.Ala290Ala synonymous_variant Exon 6 of 13 ENST00000371732.10 NP_434700.2 Q9H257-1A0A024R8F1
CARD9NM_052814.4 linkc.870G>A p.Ala290Ala synonymous_variant Exon 6 of 13 NP_434701.1 Q9H257-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CARD9ENST00000371732.10 linkc.870G>A p.Ala290Ala synonymous_variant Exon 6 of 13 1 NM_052813.5 ENSP00000360797.5 Q9H257-1
ENSG00000289701ENST00000696169.1 linkn.870G>A non_coding_transcript_exon_variant Exon 6 of 13 ENSP00000512460.1

Frequencies

GnomAD3 genomes
AF:
0.0115
AC:
1744
AN:
152234
Hom.:
37
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0397
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00399
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000279
Gnomad OTH
AF:
0.00860
GnomAD2 exomes
AF:
0.00281
AC:
679
AN:
241562
AF XY:
0.00204
show subpopulations
Gnomad AFR exome
AF:
0.0379
Gnomad AMR exome
AF:
0.00229
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000129
Gnomad OTH exome
AF:
0.00154
GnomAD4 exome
AF:
0.00118
AC:
1723
AN:
1457464
Hom.:
29
Cov.:
33
AF XY:
0.00107
AC XY:
774
AN XY:
724882
show subpopulations
African (AFR)
AF:
0.0413
AC:
1378
AN:
33386
American (AMR)
AF:
0.00225
AC:
100
AN:
44472
Ashkenazi Jewish (ASJ)
AF:
0.0000384
AC:
1
AN:
26058
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39582
South Asian (SAS)
AF:
0.0000700
AC:
6
AN:
85760
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51332
Middle Eastern (MID)
AF:
0.00348
AC:
20
AN:
5754
European-Non Finnish (NFE)
AF:
0.0000729
AC:
81
AN:
1110964
Other (OTH)
AF:
0.00226
AC:
136
AN:
60156
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
142
285
427
570
712
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0114
AC:
1744
AN:
152352
Hom.:
37
Cov.:
34
AF XY:
0.0113
AC XY:
845
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.0396
AC:
1645
AN:
41584
American (AMR)
AF:
0.00398
AC:
61
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000279
AC:
19
AN:
68018
Other (OTH)
AF:
0.00851
AC:
18
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
89
177
266
354
443
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00565
Hom.:
6
Bravo
AF:
0.0125
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Predisposition to invasive fungal disease due to CARD9 deficiency Benign:2
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
1.1
DANN
Benign
0.68
PhyloP100
-8.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115057256; hg19: chr9-139264827; API